The Use of Advantan in the Local Treatment of Genital Herpes

dc.contributor.authorIslamov Nurali Hikmatovich
dc.contributor.authorErmanov Russtam Temirovich
dc.contributor.authorNajimov Shoxboz Raximjon o’g’li
dc.date.accessioned2026-01-01T10:17:37Z
dc.date.issued2022-05-30
dc.description.abstractGenital herpes (GH) is one of the most socially significant problems in the clinical practice of dermatovenerologists, obstetricians, gynecologists, urologists. The number of patients with GH has increased by 30% over the past 10 years. The main role in the etiology of HSV belongs to HSV type 2 (HSV-2), but the pathogens of this pathology can become both HSV type 1 (HSV–1) and a combination of both types of herpes simplex virus. The prevalence of HSV-2 infection in the population ranges from 7 to 40% and averages 20%
dc.formatapplication/pdf
dc.identifier.urihttps://zienjournals.com/index.php/tjms/article/view/1814
dc.identifier.uri10.62480/tjms.2022.vol8.pp110-112
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/59355
dc.language.isoeng
dc.publisherZien Journals
dc.relationhttps://zienjournals.com/index.php/tjms/article/view/1814/1512
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceTexas Journal of Medical Science; Vol. 8 (2022): TJMS; 110-112
dc.source2770-2936
dc.subjectGenital herpes
dc.subjecttreatment
dc.subjectapplication experience
dc.subjectAdvantan
dc.titleThe Use of Advantan in the Local Treatment of Genital Herpes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
hikmatovich_2022_the_use_of_advantan_in_the_local_treatme.pdf
item.page.filesection.size
243.74 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections